logo

Adding Honesty To WSJ's Henninger's Pathetic 'Public Option'
By: Amit Chokshi   Friday, June 19, 2009 1:16 AM

Vote for next session
The next market session will close:

On June 18th, The Wall Street Journal's ("WSJ") Daniel Henninger wrote an article entitled "'Public Option': Son of Medicaid" which either ignorantly or intentionally compared the public option for US health care against Medicaid.  This comparison is disingenuous and is hardly a fair comparison to any model public plan given a number of specific aspects of Medicaid that would not be attributable to a broader public health option.  Nonetheless, the WSJ's main purpose in the context of the health care discussion has generally been to preserve the profit margins of the bloated and inefficient private insurance industry at the expense of hard working Americans.  The main way it seeks to do this is to distort and present a dishonest comparison which allows Henninger to drive support against a public option for health care.

Next Page >>12

(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Amit Chokshi



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia